CC Chemours Co
Company Analysis
Latest News
🔴 Chemours is trading 4.14% down in pre-market; catalyst unclear
Chemours is trading 4.14% down at $15.03 after closing at $15.68 on September 2, 2026; the catalyst remains unclear. - No fresh company-specific announcement,...
🟢 Chemours is trading 4.1% up today as Materials stocks gain 1.60%
Chemours is trading 4.1% up at $15.71, likely reflecting broader materials-sector strength as Materials stocks gain 1.60% during the September 2, 2026...
🔴 Chemours is trading 4.1% down today
Chemours is trading lower with no clear company-specific catalyst identified for the decline. - Trading at $15.31, down -4.10% on August 24, 2026. - No new...
🟢 Chemours is trading 5% up today amid broader chemicals and materials-sector strength
Chemours is trading 5.12% up now at $16.21, mainly as chemicals and materials stocks strengthen amid expectations for improving automotive and construction...
Chemours launches AI data center refrigerants as insider buys shares
The Chemours Company expanded its low-global-warming-potential (GWP) portfolio with the launch of Opteon ZE and Opteon 515B refrigerants. These products target...
🟢 Chemours is trading 4.23% up today
Chemours is trading 4.23% up at $15.81, with no new company-specific announcement on August 14, 2026, clearly explaining the advance. - The stock is trading...
Chemours Downgraded to 'Strong Sell' by Zacks Research
Zacks Investment Research downgraded Chemours Co. (CC) from "Strong-Buy" to "Strong Sell" in a report issued on Tuesday, August 11. The downgrade reverses the...
🟢 Chemours is trading 4.5% up today as broader markets rebound
Chemours is trading 4.5% up at $15.47 as U.S. equities move higher. - Nasdaq Composite is up 0.78% and the S&P 500 is up 0.35%. - No verified company-specific...
🟢 Chemours is trading 4.39% up in after-hours trading with no verified company-specific catalyst identified
Chemours is trading $15.45 (+4.39%) with no verified August 11 company-specific after-hours announcement or late-breaking catalyst identified. - It closed at...
🔴 Chemours is trading 5.2% down today after Morgan Stanley cut its target to $18
Chemours is trading at $14.93 (-5.21%) after Morgan Stanley reduced its price target to $18 from $21 while maintaining an Equalweight rating on August 10,...
🟢 Chemours is trading 6.68% up today amid recovery after August 5's 18.63% drop
Chemours is trading 6.68% up at $16.12, with the move appearing primarily recovery-oriented rather than tied to a confirmed fresh catalyst. - Shares fell...
Chemours Misses on Revenue and Earnings While Bleeding Red Ink — Can Cost Cuts and Debt Paydowns Outrun a Weakening Demand Cycle?
Shares of Chemours cratered nearly 10% after the specialty chemicals maker delivered a second quarter that fell short on virtually every line that matters to...
🟢 Chemours is trading 4.3% up today as materials-sector strength supports recovery
Chemours is trading at $15.21 (+4.25%) as materials-sector strength supports the recovery after its earnings-driven selloff. - August 5’s 18.63% decline...
🔴 Chemours is trading 11% down today after Q2 earnings miss and lowered Q3 guidance
Chemours is trading 11% down at $15.95 after reporting second-quarter 2026 results that missed analyst estimates for both revenue and earnings per share. •...
🔴 Chemours is trading 13% down today after missing Q2 estimates and issuing soft Q3 guidance
Chemours is trading 13% down at $15.60 after missing Q2 2026 revenue and EPS expectations and issuing soft Q3 guidance. • The company reported a large GAAP...
🔴 Chemours is trading 9.4% down today on soft Q3 guidance and refrigerant inventory headwinds
Chemours is trading 9.4% down at $16.25 following its Q2 2026 earnings report, which featured a revenue miss and cautious forward guidance. • Management...
🔴 Chemours is trading 10.1% down today after Q2 earnings miss and weak Q3 EBITDA outlook
Chemours is trading 10.1% down at $16.12 after missing Q2 2026 revenue and EPS expectations and issuing a soft outlook for the upcoming quarter. • The company...
🔴 Chemours is trading 9.8% down today after missing Q2 revenue and EPS expectations
Chemours is trading 9.8% down at $16.17 after reporting second-quarter 2026 results that missed revenue and EPS expectations. • While the company posted an...
Chemours' second quarter revenue misses estimates, but Adjusted EBITDA beats on pricing strength and APM growth.
The Chemours Company reported second quarter 2026 net sales of $1.59 billion, a 1% decrease year-over-year, missing analyst expectations. The company posted an...
🟢 Chemours is trading 4.0% up today ahead of its Q2 earnings report
Chemours is trading at $17.80 (+4.03%) as investors position ahead of its August 04, 2026, earnings report amid a broader rally in materials stocks. •...